A few weeks ago the whistleblower who broke the news on data collection integrity of Pfizer’s clinical trials did an interview with the British Medical Journal (BMJ). I thought it pertinent to put a face to the whisteblower and get her first-hand account as to what led her to decide to come clean about her observations.
It was a good interview, she was well spoken.